We have isolated a nonsense mutant in the
vps-41 gene that displays strong zygotic-effect induction of germline apoptosis, in addition to maternal-effect cytokinesis defects and embryonic arrest that are not associated with apoptosis. Apoptosis in the
vps-41 mutant is blocked by a
ced-4/APAF1 loss-of-function mutation, but not by a
cep-1/p53 deletion, suggesting that loss of
vps-41 activity induces the core apoptotic machinery independent of the DNA damage checkpoint. C. elegans
vps-41 encodes the ortholog of human and yeast VPS41. S. cerevisiae VPS41 is required for sorting of proteins to the lysosome, and specifically for the step of endosomes docking to lysosomes prior to vesicle fusion. VPS41 forms a complex with four other scaffolding proteins (VPS11, VPS16, VPS18, and VPS33), as well as the Rab GEF protein VPS39. We identified a single C. elegans ortholog for each of the five other components of the endosome-lysosome docking (or HOPS) complex, and find that RNAi of each of these genes also strongly induces germline apoptosis in wildtype or in a
cep-1/p53 deletion mutant, but not in
ced-4/APAF1 or
ced-3/caspase loss-of-function mutants. The yeast HOPS complex can also mediate docking of autophagosomes to lysosomes in the process of autophagy (degradation of cytoplasmic proteins and organelles), however RNAi of 12 homologs of yeast autophagy-specific genes does not induce germline apoptosis. RNAi of two additional genes that may be involved in lysosomal protein trafficking, as well as other functions, also induced germline apoptosis: an ortholog of human LAMPs (lysosome-associated transmembrane glycoproteins) and
unc-32, a vacuolar (H+)-ATPase V0 domain a subunit. In one plausible model, blocking endosome docking to lysosomes might lead to the accumulation of unfused endosomes that ultimately rupture to release hydrolytic enzymes into the cytoplasm, damaging mitochondria and thereby triggering apoptosis. Since most cancer cells lack
p53 function, and some also have increased protein synthesis and trafficking, inhibiting endosome-lysosome docking and fusion might provide a bypass mechanism for inducing apoptosis of tumor cells.